Let's Talk About Partial Agonists and Antagonist/Partial Agonists

In this Mental Health Minute video, John J. Miller, MD, editor in chief of Psychiatric Times^TM, discusses the importance of specifically defining a drug’s mechanism as a partial agonist or antagonist/partial agonist for improving clinical outcomes.

To learn more about partial agonists and antagonist/partial agonists, see Miller’s article from the December 2021 issue of Psychiatric Times^TM, “Is That Drug a Partial Agonist or a Partial Agonist?”

Dr Miller is medical director, Brain Health, Exeter, New Hampshire; Editor in Chief, Psychiatric Times^TM; staff psychiatrist, Seacoast Mental Health Center, Exeter; consulting psychiatrist, Exeter Hospital, Exeter; and consulting psychiatrist, Insight Meditation Society, Barre, Massachusetts.